Care/of acquired by Bayer
Bayer acquired Care/of, a US vitamins & supplements brand, on Aug 31, 2020.
Transaction summary
- Target
- Care/of
- Acquirer
- Bayer
- Seller
- -
- Announced
- 2020-08-31
- Geography
- United States
- Tags
- CPGPersonalized VitaminsSubscription WellnessSupplementsVitaminsVitamins & Supplements
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- -
- First added
- 2026-06-19
- Latest update
- 2026-06-19
Value and multiples
100% enterprise value
USD 225M
100% enterprise value | USD
Basis: Public source
Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.
EV / revenue
-
Period not stated
Basis: FundComb estimate
EV / EBITDA
-
EBITDA basis not stated
Basis: FundComb estimate
Amounts paid and other reported values
Original reported amounts and bases; a stake payment is distinct from the estimated whole-company valuation.
Unknown: USD 225M
Google News headlines from Forbes and Bloomberg state Bayer agreed/to buy Care/of at or for $225 million; Forbes describes it as a $225 million valuation, so EV/equity/consideration basis is not confirmed from fetched evidence.
Basis
- USD 225m transaction value is treated as publicly disclosed or derived directly from public source data.
- Valuation covers 100% of the target; the amount invested or paid for a stake is separate.
Source summary
No public source summary has been published for this transaction yet.